Ataxia telangiectasia and Rad3-related inhibitors and cancer therapy: where we stand

Overview of attention for article published in Journal of Hematology & Oncology, April 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

So far, Altmetric has seen 5 X posts from 2 X users, with an upper bound of 7,168 followers.

A recent review: "Ataxia telangiectasia and Rad3-related inhibitors and cancer therapy: where we stand" (https://t.co/SwyFnntSXv) #cancer https://t.co/z44GdzYcpr https://t.co/TOeH3s7669

A recent review: "Ataxia telangiectasia and Rad3-related inhibitors and cancer therapy: where we stand" (https://t.co/SwyFnntSXv) #cancer https://t.co/z44GdzYcpr

RT @WortmannLars: #DNArepair - #ATRinhibitor: "Ataxia telangiectasia and Rad3-related inhibitors and cancer therapy: where we stand" (https…

RT @WortmannLars: #DNArepair - #ATRinhibitor: "Ataxia telangiectasia and Rad3-related inhibitors and cancer therapy: where we stand" (https…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.